trending Market Intelligence /marketintelligence/en/news-insights/trending/dnBEGkSu4SzQRJ-eVAz74Q2 content esgSubNav
In This List

Vanc Pharmaceuticals CEO resigns; interim named

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Vanc Pharmaceuticals CEO resigns; interim named

Vanc Pharmaceuticals Inc. CEO Arun Nayyar resigned, effective immediately.

Bob Rai replaced Nayyar on an interim basis. Rai, who has been a director at Vanc since June 2015, is chairman and CEO of Canada Pacific Global Pharmaceuticals.